MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities$58,187K Cash and cashequivalents$41,028K Prepaid expenses andother current assets$16,069K Receivable from contractswith collaborators$9,252K Total current assets$124,536K Operating leaseright-of-use assets$3,906K Other assets$398K Property and equipment,net$59K Total assets$128,899K Accumulated deficit-$1,485,602K Accumulated othercomprehensive loss-$4,024K Total liabilities andstockholders' equity...$128,899K Total stockholders'deficit-$161,483K Additional paid-in capital$1,328,119K Common stock, 0.0001par value...$24K Total liabilities$290,382K Long-term convertiblesenior notes$198,763K Total currentliabilities$56,506K Long-term contractliabilities$31,900K Operating leaseliabilities - long-term$3,213K Accrued expenses andother current...$19,548K Accrued research anddevelopment expenses$17,395K Accounts payable$10,822K Current contractliabilities$8,741K
Balance Sheet

Gossamer Bio, Inc. (GOSS)

Gossamer Bio, Inc. (GOSS)

source: myfinsight.com